期刊文献+

前列腺癌三种放疗技术的剂量学研究 被引量:1

Dosimetry Studies of Three Different Radiotherapy Technology for Prostate Cancer
暂未订购
导出
摘要 目的在前列腺癌含盆腔淋巴引流区放疗计划中比较常规放疗(conventional radiotherapy,CRT)、三维适形放疗(three-dimensionalconformal radiotherapy,3D-CRT)和同步加量束流调强放疗(Simultaneous Modulated Accelerated Radiation Therapy,SMART)三种技术的剂量学差异。方法对分期T2-3N0M0的10例前列腺癌患者行CT扫描,勾画靶区及危及器官,分别设计以上三种计划,予相同处方剂量,前列腺和精囊70Gy,盆腔淋巴引流区50Gy。采用等剂量分布曲线,剂量-体积直方图,靶区的Dmax、Dmin、Dmean、V95%、适形指数、剂量均匀性指数及正常组织所受剂量来比较计划。结果 PTV1、PTV2靶区适形性和PTV2的剂量分布均匀性SMART较3D-CRT更佳,3D-CRT较CRT更佳(P<0.05),PTV1的剂量分布均匀性CRT较3D-CRT及SMART更佳。对直肠和股骨头的保护SMART优于3D-CRT,3D-CRT优于CRT(P<0.05)。对膀胱的保护SMART优于3D-CRT和CRT(P<0.05),3D-CRT和CRT相比较优势不明显。对小肠和结肠的保护三种方式没有差异(P<0.05)。结论综合靶区和正常组织,SMART优于3D-CRT,3D-CRT优于CRT。 Objective To compare the dosimetry differences of conventional radiotherapy(CRT),three-dimensional conformal radiotherapy(3D-CRT) and simultaneous modulated accelerated radiation therapy(SMART) in treatment planning of prostate cancer including pelvic cavity prophylactic irradiation.Methods The planning CT scans of ten patients with prostate cancer with staging of T2-3N0M0 were used to generate CRT、3D-CRT and SMART plans for this study.Target volume and organ at risk were contoured on the individual axial CT slices.Three different treatment plannings were designed for each patient with a prescription dose of 70Gy to prostate and seminal vesicle and 50Gy to pelvic lymph node.The following parameters of plannings were compared in each patient:isodose distributions line,dose-volume histogram(DVH),Dmax,Dmin,Dmean,V95%,CI(radiation conformal index,CI)、HI(relative dose homogeneity index,HI)and the dose to related critical organs.Results SMART showed better dose uniformity and conformity than 3D-CRT and CRT,and 3D-CRT was superior to CRT except in PTV1(P0.05).SMART was superior to 3D-CRT,and 3D-CRT was superior to CRT in sparing rectum and femoral head(P0.05).SMART was superior to 3D-CRT and 3D-CRT in sparing bladder(P 0.05).But the dose received by the intestine and colon were not significant different(P0.05).Conclusion Considering the target volume and critical organs,plans of SMART were superior to 3D-CRT and 3D-CRT were superior to CRT.SMART showed advantages in prostate cancer radiotherapy with nodal treatment.
出处 《中国医药指南》 2012年第34期44-46,共3页 Guide of China Medicine
关键词 前列腺肿瘤 放射疗法 放疗技术 剂量学 Prostate cancer/radiotherapy Radiotherapy technology Dosimetry
  • 相关文献

参考文献12

  • 1Aus G,Abbou CC,Bolla M,et al.EAU guidelines on prostate cancer[J].Eur Urol,2005,48(4):546-551.
  • 2许素玲,王海峰.调强放射治疗临床应用研究现状[J].新疆医科大学学报,2005,28(8):714-716. 被引量:2
  • 3Radiation Therapy Oncology Group RTOG 0521.A Phase Ⅲ Protocol of Androgen Suppression (AS) and 3D-CRT/IMRT VS AS and 3D-CRT/IMRT Followed by Chemotherapy with Docetaxel Prednisone for Localized,High-Risk Prostate Cancer[EB/OL]. http://my.clevelandclinic.org/research/ clinical_trials/cancer/a_phase_iii_protocol of androgen_suppre ssion and 3.aspx.
  • 4Jackson AS,Sohaib SA,Staffurth JN,et al.Distribution of Lymph Nodes in Men with Prostatic Adenocarcinoma and Lymphadenopathy at Presentation:A Retrospective Radiological Review and'Implications for Prostate and Pelvis Radiotherapy[J]. Clin Oncol,2006,18(2):109-116.
  • 5Taylor A,Rockall AC,Reznek RH,et al.Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy[J].Int J Radiation Oncology Biol Phys,2005,63(5):1604-1612.
  • 6金大伟,戴建荣,李晔雄,余子豪.前列腺癌调强放疗的治疗方案比较[J].中华放射肿瘤学杂志,2005,14(1):47-51. 被引量:43
  • 7Murshed H,Liu HL,Liao Z,et al.Dose and volume reduction for nomal lung using intensitymodnlated radiotherapy for advanced stage non-small-cell lung cancer[J].Int J Radiat Oncol Biol Phys, 2004,58(4):1258-1267.
  • 8Roach M Ⅲ,DeSilvio M,Lawton C,et al.Phase Ⅲ Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413[J].J Clin Oncol,2003,21(10):1904-1911.
  • 9Pollack A,Zagars GK, Starkschall G,et al.Prostate cancer radiation dose response: results of the MD Anderson phase Ⅲ randomised trial[J].Int J Radiat Oncol Biol Phys,2002,53(5):1097-1105.
  • 10Kuban D,Pollack A,Huang E,et al.Hazards of escalation in prostate cancer radiotherapy[J].Int J Radiat Oncol Biol Phys,2003, 57(5):1260-1268.

二级参考文献8

  • 1赵充,韩非,卢丽霞,黄劭敏,林承光,邓小武,卢泰祥,崔念基.调强适形放射治疗对局部晚期鼻咽癌的临床疗效[J].癌症,2004,23(Z1):1532-1537.
  • 2Gert O,Luc A,Werner RT,et al.Robert AP,Gerald EH,Shawn WM,et al. Radiotherapy of Prostate Cancer with or without Intensity Modulated Beams:a Planning Comparison.Int J Radiat Oncol Biol Phys,2000,47:639-648.
  • 3Robert AP, Gerald EH, Shawn WM, et al. Advantages of Using Noncoplanar vs Axial Beam Arrangements when Treating Prostate Cancer with Intensity-Modulated Radiation Therapy and the Step-and Shoot Delivery Method. Int J Radiat Oncol Biol Phys,2002,53:236-243.
  • 4Pollack A,Zagers Gk,Statkschall G,et al.Prostate Cancer Badiation Dose Response:results of the M.D.Anderson Phase Ⅲ Randomized Trial.lnt J Radiat Oneol Biol Phys,2002,53:1097-1105.
  • 5Storey MR,Pollack A,Zagars G,et al.Complications from Radiotherapy Dose Escalation in Prostate Cancer:preliminary Results of A Randomized Trial.Int J Radiat Oncol Biol Phys,2000,48:635-642.
  • 6Mohan R, Wu Q,Manning M,et al. Radiobiological considerations in the design of fractionation strategies for intensity modulated radiation therapy of head and neck cancers.Int J Radiat Oncol Biol Phys,2000,46:619-630.
  • 7Bragg CM,Conway J,Robinson MH,et al.The role of intersity modulated radiotherapy in the treatment of parotid tumors. Int J Radiat Oncol Biol Phys,2002,52:729-738.
  • 8Wei-HuaFu Lu-HuaWang Zong-MeiZhou Jian-RongDai Yi-MinHu Lu-JunZhao.Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma[J].World Journal of Gastroenterology,2004,10(8):1098-1102. 被引量:92

共引文献43

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部